Work

Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.2532

Authors: R. A. Figlin, C. A. Nicolette, A. Amin, A. Dudek, T. Logan, R. S. Lance, J. M. Holzbeierlein, S. K. Pal, V. A. Master, M. DeBenedette, I. Y. Tcherepanova, R. Jain, W. L. Williams, F. Miesowicz, T. Monesmith

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2565460156

Cites:

Cited by: 21

Related to: 10